
Esco Lifesciences
Asia, Central Region, Singapore, Singapore'/%3e%3cuse xlink:href='%23a' transform='translate(288.889 -214.211)'/%3e%3cuse xlink:href='%23a' transform='translate(108 342.749)'/%3e%3cuse xlink:href='%23a' transform='translate(469.189 342.749)'/%3e%3c/svg%3e)
Description
Esco Lifesciences provides enabling technologies, products, and services.
Investor Profile
Esco Lifesciences has backed more than 3 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Seed, Corporate Round rounds (top funding stages).
- Majority of deals are located in United Kingdom, United States.
- Strong thematic focus on Biotechnology, Health Care, Medical Device.
Stage Focus
- Series A (33%)
- Seed (33%)
- Corporate Round (33%)
Country Focus
- United Kingdom (67%)
- United States (33%)
Industry Focus
- Biotechnology
- Health Care
- Medical Device
- Agriculture
- Agtech
- Alternative Protein
- Genetics
- Manufacturing
- Women's
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.